M. J. Parsonage

1.3k total citations
23 papers, 442 citations indexed

About

M. J. Parsonage is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, M. J. Parsonage has authored 23 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 9 papers in Pediatrics, Perinatology and Child Health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in M. J. Parsonage's work include Epilepsy research and treatment (11 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). M. J. Parsonage is often cited by papers focused on Epilepsy research and treatment (11 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). M. J. Parsonage collaborates with scholars based in United Kingdom and France. M. J. Parsonage's co-authors include J. W. A. Turner, John W. Norris, Mohamed N. Hassan, A.N.G. Clark, Christopher Gardner‐Thorpe, C. J. Vas, C. Toothill, Gavin Barlow, Kate Adams and H. Thaker and has published in prestigious journals such as The Lancet, Journal of Neurology Neurosurgery & Psychiatry and Epilepsia.

In The Last Decade

M. J. Parsonage

21 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. J. Parsonage United Kingdom 9 172 170 119 111 87 23 442
R. Brun del Re Canada 9 139 0.8× 100 0.6× 28 0.2× 10 0.1× 62 0.7× 16 452
H. Bootsma Netherlands 11 282 1.6× 378 2.2× 124 1.0× 11 0.1× 113 1.3× 12 655
Patrick G. Burch United States 8 22 0.1× 57 0.3× 75 0.6× 21 0.2× 29 0.3× 9 387
Ben Ami Sela Israel 9 37 0.2× 47 0.3× 59 0.5× 18 0.2× 47 0.5× 14 395
John H. Tyrer Australia 8 176 1.0× 160 0.9× 21 0.2× 8 0.1× 30 0.3× 15 403
M. Sovák United States 11 17 0.1× 56 0.3× 38 0.3× 38 0.3× 19 0.2× 33 369
M. Recchia Italy 10 40 0.2× 38 0.2× 37 0.3× 11 0.1× 79 0.9× 27 362
Kate Gerber Switzerland 13 191 1.1× 115 0.7× 127 1.1× 11 0.1× 10 0.1× 35 514
M. Laundy United Kingdom 10 106 0.6× 104 0.6× 31 0.3× 5 0.0× 22 0.3× 13 433
J. Dobkin United States 11 33 0.2× 22 0.1× 30 0.3× 56 0.5× 99 1.1× 24 556

Countries citing papers authored by M. J. Parsonage

Since Specialization
Citations

This map shows the geographic impact of M. J. Parsonage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. J. Parsonage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. J. Parsonage more than expected).

Fields of papers citing papers by M. J. Parsonage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. J. Parsonage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. J. Parsonage. The network helps show where M. J. Parsonage may publish in the future.

Co-authorship network of co-authors of M. J. Parsonage

This figure shows the co-authorship network connecting the top 25 collaborators of M. J. Parsonage. A scholar is included among the top collaborators of M. J. Parsonage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. J. Parsonage. M. J. Parsonage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parsonage, M. J., Gavin Barlow, Patrick Lillie, et al.. (2009). Severe myositis on commencement of efavirenz, abacavir and lamivudine, in the absence of lactic acidosis or classical abacavir hypersensitivity. BMJ Case Reports. 2009. bcr0120091411–bcr0120091411. 4 indexed citations
2.
Parsonage, M. J.. (2004). Lesson of the week: a new cause of treatable dementia. Age and Ageing. 33(3). 315–316.
3.
Parsonage, M. J., et al.. (1988). Phenytoin-induced gum hypertrophy in patients with epilepsy. Current Medical Research and Opinion. 10(10). 652–655. 3 indexed citations
4.
Parsonage, M. J.. (1977). Antiepileptic Drug Monitoring. Journal of Neurology Neurosurgery & Psychiatry. 40(11). 1125–1125. 83 indexed citations
5.
Hassan, Mohamed N., et al.. (1976). SODIUM VALPROATE IN the TREATMENT of RESISTANT EPILEPSY. Acta Neurologica Scandinavica. 54(3). 209–218. 47 indexed citations
6.
Parsonage, M. J.. (1973). The Differential Diagnosis of Seizures. Journal of the Royal College of Physicians of London. 7(3). 213–234. 7 indexed citations
7.
Gardner‐Thorpe, Christopher, et al.. (1972). A comprehensive gas chromatographic scheme for the estimation of antiepileptic drugs. Clinica Chimica Acta. 36(1). 223–230. 26 indexed citations
8.
Gardner‐Thorpe, Christopher, M. J. Parsonage, & C. Toothill. (1971). A comprehensive scheme for the evaluation of anticonvulsant concentrations in blood using thin-layer chromatography. Clinica Chimica Acta. 35(1). 39–47. 12 indexed citations
9.
Parsonage, M. J. & John W. Norris. (1970). USE OF DIAZEPAM IN TREATMENT OF SEVERE CONVULSIVE STATUS EPILEPTICUS. Survey of Anesthesiology. 14(3). 217–217.
10.
Parsonage, M. J., et al.. (1969). Mutation in Huntington's chorea.. Journal of Neurology Neurosurgery & Psychiatry. 32(2). 140–143. 27 indexed citations
11.
Parsonage, M. J. & John W. Norris. (1967). Use of diazepam in treatment of severe convulsive status epilepticus.. BMJ. 3(5557). 85–88. 42 indexed citations
12.
Vas, C. J., et al.. (1967). An appraisal of hyoscine as an EEG activating agent. Electroencephalography and Clinical Neurophysiology. 22(4). 373–377. 6 indexed citations
13.
Vas, C. J. & M. J. Parsonage. (1967). TREATMENT OF INTRACTABLE TEMPORAL LOBE EPILEPSY WITH PHENETURIDE. Acta Neurologica Scandinavica. 43(5). 580–586. 15 indexed citations
14.
Vas, C. J., et al.. (1967). Activation of the EEG by Procyclidine Hydrochloride in Temporal Lobe Epilepsy. Epilepsia. 8(4). 241–251. 3 indexed citations
15.
Parsonage, M. J.. (1966). Modern treatment of epilepsy.. PubMed. 17(4). 202–6. 1 indexed citations
16.
Parsonage, M. J., et al.. (1964). USE AND ABUSE OF ELECTROENCEPHALOGRAPHY. The Lancet. 284(7362). 753–753. 2 indexed citations
17.
Turner, J. W. A. & M. J. Parsonage. (1957). NEURALGIC AMYOTROPHY (PARALYTIC BRACHIAL NEURITIS). The Lancet. 270(6988). 209–212. 123 indexed citations
18.
Clark, A.N.G. & M. J. Parsonage. (1957). A Case of Podophyllum Poisoning with Involvement of the Nervous System. BMJ. 2(5054). 1155–1157. 28 indexed citations
19.
Parsonage, M. J.. (1955). Differential Diagnosis of Coma. BMJ. 1(4907). 217–219. 1 indexed citations
20.
Parsonage, M. J., D. Taverner, & G. H. Wooler. (1955). Paraplegia Following the Use of "Efocaine". BMJ. 1(4925). 1322–1323. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026